Author

Andrew Porter

Newcastle UniversityPrimary ORCID profile (0000-0002-0757-9479 · 6 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Andrew PorteriD6 papers · Newcastle University

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1

Frequent Co-Authors

Andrea C. MasiiD· 1 shared Andrew NelsoniD· 1 shared Christopher Andrew LambiD· 1 shared Christopher James StewartiD· 1 shared Gregory R. YoungiD· 1 shared Hannah WatsoniD· 1 shared Hilary P. BrowneiD· 1 shared James P. R. ConnollyiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Andrea C. MasiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Human milk oligosaccharide metabolism by Clostridium species suppresses inflammation and pathogen growth

Jonathan A. Chapman, Andrea C. Masi, Lauren C. Beck, Hannah Watson, Gregory R. Young, Hilary P. Browne, Yan Shao, Raymond Kiu, Andrew Nelson, Jennifer A Doyle, Paweł Palmowski, Márton Lengyel, James P. R. Connolly, Christopher Andrew Lamb, Andrew Porter, , Christopher James Stewart

The paper identifies Clostridium species that metabolize human milk oligosaccharides, producing beneficial metabolites and suppressing inflammation and pathogen growth in preterm infants.

bioRxiv · Jan 21, 2025 · PreprintMicrobiology